Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Litx System in Refractory Colorectal Liver Metastases
NCT00068068Phase 2Completed
- Sponsor
- Light Science Oncology
- Start
- Oct 2003
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of talaporfin sodium in colorectal cancer (CRC), sponsored by Light Science Oncology. Started Oct 2003; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00068068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068068.